Study Shows Highly Promising New Class Of Anti-Cancer Drugs

The New England Journal of Medicine has published a study today that shows stunning results of a new class of anti-cancer drugs known as PARP inhibitors. Scientists think this the class of drugs might be effective against breast, ovarian, and prostate cancers among others.

This entry was posted on Thursday, June 25th, 2009 at 11:27 am and is filed under Medical News Wire. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.